Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS628 vs tocilizumab in rheumatoid arthritis
CTR20201263Phase 3Completed
- Sponsor
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of HS628 in rheumatoid arthritis (RA), sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Started Jul 2020; status: completed.
02
Drugs
HS628
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20201263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201263.